Document Detail

In-Hospital STEMI: An Inside Out Approach.
MedLine Citation:
PMID:  24389238     Owner:  NLM     Status:  Publisher    
The clinical benefit of reducing the time between the onset of ST-segment elevation myocardial infarction (STEMI) and coronary reperfusion has been a motivating principle for cardiologists and their emergency care colleagues for the past two decades(1). Prompt treatment with fibrinolytic therapy or primary percutaneous coronary intervention (PCI) leads to improved outcomes and important reductions in mortality(2). Development and optimization of systems of care to improve treatment times for STEMI patients has been a major initiative of the national cardiovascular organizations as well as regional healthcare networks for nearly ten years.
Ashvin N Pande; Alice K Jacobs
Related Documents :
15861408 - Analysis of the proepicardium-epicardium transition during the malformation of the rxra...
20352158 - Differential effect of ischaemic preconditioning on mobilisation and recruitment of hae...
11996268 - Role of apoptosis in myocardial stunning after open heart surgery.
21059858 - Long-term improvement in postinfarct left ventricular global and regional contractile f...
10407858 - Cardiac involvement in carriers of duchenne and becker muscular dystrophy.
18703358 - Blue dye, green heart.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-3
Journal Detail:
Title:  Circulation     Volume:  -     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-1-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  ST Elevation Myocardial Infarction Diagnosed after Hospital Admission.
Next Document:  Clinical experience of IL-6 blockade in rheumatic diseases-Implications on IL-6 biology and disease ...